INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-2223536069 protein]( "Development Of A Non-Standard Protein Therapeutic")
Development Of A Non-Standard Protein TherapeuticDiscover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.
-
![GettyImages-2081051230-3d-bioprinting-organs-doctors]( "Assessment Of Compound Toxicity Effects With High-Content Imaging")
Assessment Of Compound Toxicity Effects With High-Content Imaging3D cellular models and bioprinting enhance drug safety predictions and offer precise spatial control. Explore an automated method for generating liver models to improve reproducibility and reliability in toxicity testing.
-
![Weight Loss_GettyImages-2123088969]( "Advancements In GLP-1 Analog Formulation: Overcoming Challenges")
Advancements In GLP-1 Analog Formulation: Overcoming ChallengesOral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.
-
![Laboratory Research GettyImages-1293773554]( "Improving API Solubility Using Spray Drying With Polyvinyl Alcohol")
Improving API Solubility Using Spray Drying With Polyvinyl AlcoholEnhancing the solubility of poorly soluble APIs is vital for improving bioavailability. Discover how advanced formulation techniques like hot-melt extrusion and spray drying can overcome this challenge.
-
The Global Leader In Organ-On-A-Chip Technology8/2/2024
What are organ chips, and how are they being used to better predict the human body's response to medications, food, and chemicals?
-
How To Choose The Right CDMO For Your Pharmaceutical Project- Part One: Will They Deliver?4/17/2024
Choosing the right CDMO is crucial for the success of your pharmaceutical project. Learn how to strike the ideal balance between an organization's technical expertise, facilities, and efficiency.
-
Lentiviral Vector Upstream Process12/12/2025
Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.
-
Cell Cycle Mapping In Tumors With Advanced Technologies9/2/2025
Discover how spatial profiling and advanced imaging tools are transforming drug discovery, featuring Wayne Stallaert’s lab’s work on cell cycle mapping and biomarker insights in cancer research.
-
Understanding Adeno-Associated Virus Vector Impurities11/13/2025
AAV vectors hold promise for gene therapy, but removing product-related impurities remains a challenge. Learn how cell line development and process optimization are advancing rAAV production.
DRUG DEVELOPMENT SOLUTIONS
-
![Samsung]( "The Power Of One: mRNA Services")
We offer mRNA drug substance, formulated bulk drug product manufacturing (encapsulation), and fill/finish from a single site.
-
![Waters GLP-1 RA Solution Image]( "GLP-1 Receptor Agonist Solutions")
The journey of a GLP-1 receptor agonist (GLP-1 RA) molecule is complex.
-
Access all the service, support, and performance maintenance options you need for uninterrupted performance – giving your lab more control over your service, maintenance costs, and enabling you to optimize your laboratory productivity.
-
![SpectraMax iD3s_right facing_53 (1)]( "Multi-Mode Microplate Reader")
Unlock precision and flexibility with an affordable, high-performance solution for absorbance, fluorescence, and luminescence assays, with advanced upgrades for live-cell analysis.
-
![GettyImages-1327977866-cell-culture-sample-laboratory]( "Powering Production Of Viral Vector-Based Therapies")
Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.
